Cite
MLA Citation
Claire F Friedman et al.. “Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses.” Journal for immunotherapy of cancer, vol. 10, no. 1, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100150524100.0x00000c